OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New perspectives in glutamate and anxiety
C. Riaza Bermudo-Soriano, M. Mercedes Pérez-Rodríguez, Concepción Vaquero‐Lorenzo, et al.
Pharmacology Biochemistry and Behavior (2011) Vol. 100, Iss. 4, pp. 752-774
Closed Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, FIFTH EDITION
Attari Abbas, Mahin Aminoroaia
(2013) Vol. 11, Iss. 226, pp. 148-156
Closed Access | Times Cited: 1364

Moving Forward: Challenges and Directions for Psychopathological Network Theory and Methodology
Eiko I. Fried, Angélique O. J. Cramer
Perspectives on Psychological Science (2017) Vol. 12, Iss. 6, pp. 999-1020
Open Access | Times Cited: 702

Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
Adriana Feder, Michael K. Parides, James W. Murrough, et al.
JAMA Psychiatry (2014) Vol. 71, Iss. 6, pp. 681-681
Closed Access | Times Cited: 528

Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders
Nicolas Singewald, Claudia Schmuckermair, Nigel Whittle, et al.
Pharmacology & Therapeutics (2014) Vol. 149, pp. 150-190
Open Access | Times Cited: 375

The Role of Magnesium in Neurological Disorders
Anna E. Kirkland, Gabrielle L. Sarlo, Kathleen F. Holton
Nutrients (2018) Vol. 10, Iss. 6, pp. 730-730
Open Access | Times Cited: 265

Understanding resilience: New approaches for preventing and treating PTSD
Sarah R. Horn, Dennis S. Charney, Adriana Feder
Experimental Neurology (2016) Vol. 284, pp. 119-132
Closed Access | Times Cited: 195

NMDA Receptor Antagonists: Emerging Insights into Molecular Mechanisms and Clinical Applications in Neurological Disorders
Ayodeji O. Egunlusi, Jacques Joubert
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 639-639
Open Access | Times Cited: 18

Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies
Lynnette A. Averill, Prerana Purohit, Christopher L. Averill, et al.
Neuroscience Letters (2016) Vol. 649, pp. 147-155
Open Access | Times Cited: 162

Serotonin in fear conditioning processes
Elizabeth P. Bauer
Behavioural Brain Research (2014) Vol. 277, pp. 68-77
Closed Access | Times Cited: 128

Adult vitamin D deficiency leads to behavioural and brain neurochemical alterations in C57BL/6J and BALB/c mice
Natalie J. Groves, James P. Kesby, Darryl W. Eyles, et al.
Behavioural Brain Research (2012) Vol. 241, pp. 120-131
Closed Access | Times Cited: 127

Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence
Sophie Holmes, Matthew J. Girgenti, Margaret T. Davis, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 31, pp. 8390-8395
Open Access | Times Cited: 121

Ketamine accelerates fear extinction via mTORC1 signaling
Matthew J. Girgenti, Sriparna Ghosal, Dora Lopresto, et al.
Neurobiology of Disease (2016) Vol. 100, pp. 1-8
Open Access | Times Cited: 114

N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review
Georgina Oliver, Olivia Dean, David Camfield, et al.
Clinical Psychopharmacology and Neuroscience (2015) Vol. 13, Iss. 1, pp. 12-24
Open Access | Times Cited: 97

Synaptic Plasticity, Metaplasticity and Depression
Linnea R. Vose, Patric K. Stanton
Current Neuropharmacology (2016) Vol. 15, Iss. 1, pp. 71-86
Open Access | Times Cited: 97

Psychiatric comorbidities in patients with alopecia areata in Taiwan: a case-control study
S-Y. Chu, Yi‐Ju Chen, Wei‐Cheng Tseng, et al.
British Journal of Dermatology (2011) Vol. 166, Iss. 3, pp. 525-531
Closed Access | Times Cited: 100

Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: Implications for underlying fear circuits
Nesha S. Burghardt, Elizabeth P. Bauer
Neuroscience (2013) Vol. 247, pp. 253-272
Closed Access | Times Cited: 98

Gestational and lactational exposure to bisphenol-A affects anxiety- and depression-like behaviors in mice
Xiaohong Xu, Hong Xing, Lingdan Xie, et al.
Hormones and Behavior (2012) Vol. 62, Iss. 4, pp. 480-490
Closed Access | Times Cited: 90

Chronic Antidepressant Treatment Impairs the Acquisition of Fear Extinction
Nesha S. Burghardt, Torfi Sigurdsson, Jack M. Gorman, et al.
Biological Psychiatry (2012) Vol. 73, Iss. 11, pp. 1078-1086
Open Access | Times Cited: 85

N-acetylcysteine prevents stress-induced anxiety behavior in zebrafish
Ricieri Mocelin, Ana Paula Herrmann, Matheus Marcon, et al.
Pharmacology Biochemistry and Behavior (2015) Vol. 139, pp. 121-126
Closed Access | Times Cited: 82

Neuronal nitric oxide synthase and affective disorders
Qi‐Gang Zhou, Xian‐Hui Zhu, Ashley D. Nemes, et al.
IBRO Reports (2018) Vol. 5, pp. 116-132
Open Access | Times Cited: 82

Negative childhood experiences alter a prefrontal‐insular‐motor cortical network in healthy adults: A preliminary multimodal rsfMRI‐fMRI‐MRS‐dMRI study
Niall W. Duncan, Dave J. Hayes, Christine Wiebking, et al.
Human Brain Mapping (2015) Vol. 36, Iss. 11, pp. 4622-4637
Open Access | Times Cited: 80

Page 1 - Next Page

Scroll to top